- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.22 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x QNG: N-[(1S)-1-(3-{4-chloro-3-[(methylsulfonyl)amino]-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl}-6-[3-methyl-3-(methylsulfonyl)but-1-yn-1-yl]pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl]-2-[(3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl]acetamide(Non-covalent)
- 6 x IOD: IODIDE ION(Non-functional Binders)
IOD.2: 4 residues within 4Å:- Chain A: G.156, P.157, K.158, E.159
Ligand excluded by PLIPIOD.10: 4 residues within 4Å:- Chain B: G.156, P.157, K.158, E.159
Ligand excluded by PLIPIOD.18: 4 residues within 4Å:- Chain C: G.156, P.157, K.158, E.159
Ligand excluded by PLIPIOD.26: 4 residues within 4Å:- Chain D: G.156, P.157, K.158, E.159
Ligand excluded by PLIPIOD.34: 4 residues within 4Å:- Chain E: G.156, P.157, K.158, E.159
Ligand excluded by PLIPIOD.42: 4 residues within 4Å:- Chain F: G.156, P.157, K.158, E.159
Ligand excluded by PLIP- 36 x CL: CHLORIDE ION(Non-functional Binders)
CL.3: 2 residues within 4Å:- Chain A: L.172, E.175
Ligand excluded by PLIPCL.4: 3 residues within 4Å:- Chain A: R.162, M.215
- Chain E: M.144
Ligand excluded by PLIPCL.5: 5 residues within 4Å:- Chain A: Q.50, N.53, G.106, Q.114
- Ligands: QNG.1
Ligand excluded by PLIPCL.6: 2 residues within 4Å:- Chain E: P.17, R.18
Ligand excluded by PLIPCL.7: 2 residues within 4Å:- Chain A: Q.63
- Chain F: K.170
Ligand excluded by PLIPCL.8: 1 residues within 4Å:- Ligands: QNG.1
Ligand excluded by PLIPCL.11: 2 residues within 4Å:- Chain B: L.172, E.175
Ligand excluded by PLIPCL.12: 3 residues within 4Å:- Chain B: R.162, M.215
- Chain F: M.144
Ligand excluded by PLIPCL.13: 5 residues within 4Å:- Chain B: Q.50, N.53, G.106, Q.114
- Ligands: QNG.9
Ligand excluded by PLIPCL.14: 2 residues within 4Å:- Chain F: P.17, R.18
Ligand excluded by PLIPCL.15: 2 residues within 4Å:- Chain B: Q.63
- Chain D: K.170
Ligand excluded by PLIPCL.16: 1 residues within 4Å:- Ligands: QNG.9
Ligand excluded by PLIPCL.19: 2 residues within 4Å:- Chain C: L.172, E.175
Ligand excluded by PLIPCL.20: 3 residues within 4Å:- Chain C: R.162, M.215
- Chain D: M.144
Ligand excluded by PLIPCL.21: 5 residues within 4Å:- Chain C: Q.50, N.53, G.106, Q.114
- Ligands: QNG.17
Ligand excluded by PLIPCL.22: 2 residues within 4Å:- Chain D: P.17, R.18
Ligand excluded by PLIPCL.23: 2 residues within 4Å:- Chain C: Q.63
- Chain E: K.170
Ligand excluded by PLIPCL.24: 1 residues within 4Å:- Ligands: QNG.17
Ligand excluded by PLIPCL.27: 2 residues within 4Å:- Chain D: L.172, E.175
Ligand excluded by PLIPCL.28: 3 residues within 4Å:- Chain B: M.144
- Chain D: R.162, M.215
Ligand excluded by PLIPCL.29: 5 residues within 4Å:- Chain D: Q.50, N.53, G.106, Q.114
- Ligands: QNG.25
Ligand excluded by PLIPCL.30: 2 residues within 4Å:- Chain B: P.17, R.18
Ligand excluded by PLIPCL.31: 2 residues within 4Å:- Chain C: K.170
- Chain D: Q.63
Ligand excluded by PLIPCL.32: 1 residues within 4Å:- Ligands: QNG.25
Ligand excluded by PLIPCL.35: 2 residues within 4Å:- Chain E: L.172, E.175
Ligand excluded by PLIPCL.36: 3 residues within 4Å:- Chain C: M.144
- Chain E: R.162, M.215
Ligand excluded by PLIPCL.37: 5 residues within 4Å:- Chain E: Q.50, N.53, G.106, Q.114
- Ligands: QNG.33
Ligand excluded by PLIPCL.38: 2 residues within 4Å:- Chain C: P.17, R.18
Ligand excluded by PLIPCL.39: 2 residues within 4Å:- Chain A: K.170
- Chain E: Q.63
Ligand excluded by PLIPCL.40: 1 residues within 4Å:- Ligands: QNG.33
Ligand excluded by PLIPCL.43: 2 residues within 4Å:- Chain F: L.172, E.175
Ligand excluded by PLIPCL.44: 3 residues within 4Å:- Chain A: M.144
- Chain F: R.162, M.215
Ligand excluded by PLIPCL.45: 5 residues within 4Å:- Chain F: Q.50, N.53, G.106, Q.114
- Ligands: QNG.41
Ligand excluded by PLIPCL.46: 2 residues within 4Å:- Chain A: P.17, R.18
Ligand excluded by PLIPCL.47: 2 residues within 4Å:- Chain B: K.170
- Chain F: Q.63
Ligand excluded by PLIPCL.48: 1 residues within 4Å:- Ligands: QNG.41
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bester, S.M. et al., Structural and mechanistic bases for a potent HIV-1 capsid inhibitor. Science (2020)
- Release Date
- 2020-10-21
- Peptides
- Capsid protein p24: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
CC
CD
CE
CF
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.22 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x QNG: N-[(1S)-1-(3-{4-chloro-3-[(methylsulfonyl)amino]-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl}-6-[3-methyl-3-(methylsulfonyl)but-1-yn-1-yl]pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl]-2-[(3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl]acetamide(Non-covalent)
- 6 x IOD: IODIDE ION(Non-functional Binders)
- 36 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bester, S.M. et al., Structural and mechanistic bases for a potent HIV-1 capsid inhibitor. Science (2020)
- Release Date
- 2020-10-21
- Peptides
- Capsid protein p24: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
CC
CD
CE
CF
C